Integrity Alliance LLC. Invests $526,000 in VanEck Pharmaceutical ETF $PPH

Integrity Alliance LLC. acquired a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the fourth quarter, HoldingsChannel reports. The fund acquired 5,101 shares of the company’s stock, valued at approximately $526,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. AlphaCore Capital LLC acquired a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth $31,000. IFP Advisors Inc increased its holdings in shares of VanEck Pharmaceutical ETF by 53.7% during the 3rd quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after buying an additional 153 shares during the last quarter. Advisory Services Network LLC acquired a new stake in shares of VanEck Pharmaceutical ETF during the 3rd quarter worth $41,000. CWM LLC increased its holdings in shares of VanEck Pharmaceutical ETF by 36.3% during the 4th quarter. CWM LLC now owns 511 shares of the company’s stock worth $53,000 after buying an additional 136 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its holdings in shares of VanEck Pharmaceutical ETF by 64.7% during the 4th quarter. Farther Finance Advisors LLC now owns 718 shares of the company’s stock worth $74,000 after buying an additional 282 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Down 0.9%

PPH stock opened at $104.74 on Friday. The company has a market cap of $993.98 million, a price-to-earnings ratio of 20.21 and a beta of 0.46. The business has a fifty day simple moving average of $102.50 and a 200-day simple moving average of $103.94. VanEck Pharmaceutical ETF has a 52 week low of $81.74 and a 52 week high of $112.58.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 7th. Stockholders of record on Wednesday, April 1st were issued a dividend of $0.8441 per share. This represents a $3.38 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date was Wednesday, April 1st. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.